Acute and Late Toxicity in Radical Radiotherapy of Prostate Cancer

被引:1
|
作者
Josifovski, Tatjana [1 ]
Tulic, Cane [2 ]
Milosevic, Aleksandar [3 ]
Radosevic-Jelic, Ljiljana [1 ]
机构
[1] Inst Oncol & Radiol Serbia, Belgrade 11000, Serbia
[2] Clin Ctr Serbia, Inst Urol & Nephrol, Belgrade, Serbia
[3] Clin Hosp Ctr Zvezdara, Clin Inst Urol, Belgrade, Serbia
关键词
prostate cancer; radical radiotherapy; acute toxicity; late toxicity; SELF-ASSESSMENT QUESTIONNAIRE; ADENOCARCINOMA; RADIATION;
D O I
10.2298/SARH0902038J
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction Although radical radiotherapy has proved to be a successful method in prostate cancer treatment, the conventional (box) technique can result in significant adverse events. Objective The objective of our study was to estimate the frequency, type and severity of acute and late toxicity in radical radiotherapy of prostate cancer. Methods In a clinical retrospective study, we included 283 patients with histologically confirmed prostate cancer. All our patients received radical, conventional radiotherapy using the four-field technique. The study was performed at the Radiotherapy Department of the Institute for Oncology and Radiology of Serbia between January 1991 and December 2005. During regular follow-up, we analysed the frequency, type and severity of acute and late toxicity. Results Two thirds (71%) of our patients had acute toxicity of at least one organ within the radiation field. Most frequent complication was radiation dermatitis (10.5%, and enteritis (9%), cystitis (6%) and proctitis (2.5%). Acute adverse events were mostly low grade (I and II, 28-61%). Late complications were registered in 20.5% of patients. Skin fibrosis was most frequent (12%). Chronic proctitis was detected in 4% and urethral stricture in 4.5% of our patients. All late complications were low grade. Conclusion Treatment tolerance of radical radiotherapy is relatively good. Although most patients develop acute toxicity, it is commonly low grade and requires the interruption of radiotherapy treatment in 20% of patients only. Late toxicity is rarer than acute and, in most cases, it does not affect the quality of life.
引用
收藏
页码:38 / 42
页数:5
相关论文
共 50 条
  • [1] Acute and Late Toxicity in Radical Radiotherapy for Bladder Cancer
    Majewski, W.
    Tarnawski, R.
    [J]. CLINICAL ONCOLOGY, 2009, 21 (08) : 598 - 609
  • [2] Acute and late genitourinary toxicity of conformal radiotherapy for prostate cancer
    Yoshimura R.-I.
    Iwata M.
    Shibuya H.
    Sakai Y.
    Kihara K.
    [J]. Radiation Medicine, 2006, 24 (8): : 553 - 559
  • [3] Acute- and late toxicity after percutaneous radiotherapy of prostate cancer
    Brinkmann, R.
    Niewald, M.
    Fleckenstein, V.
    Wullich, B.
    Ruebe, C.
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2007, 183 : 117 - 117
  • [4] LATE TOXICITY OF RADICAL RADIOTHERAPY TO THE PROSTATE IN YOUNG VERSUS OLDER MEN WITH NON METASTATIC PROSTATE CANCER
    Driscoll, C.
    Montazeri, A.
    Myint, W.
    Wong, H.
    Syndikus, I.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2011, 99 : S385 - S385
  • [5] PROSTATE CONFORMAL RADIOTHERAPY: ACUTE AND LATE RECTAL TOXICITY
    Molinaro, M. A.
    Pingitore, D.
    Mole, R.
    [J]. ANTICANCER RESEARCH, 2004, 24 (5D) : 3567 - 3568
  • [6] Acute and late gastrointestinal toxicity after radiotherapy in prostate cancer patients: Consequential late damage
    Heemsbergen, Wilma D.
    Peeters, Stephanie T. H.
    Koper, Peter C. M.
    Hoogeman, Mischa S.
    Lebesque, Joos V.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (01): : 3 - 10
  • [7] Genitourinary and gastrointestinal toxicity after radical radiotherapy for prostate cancer
    Redmond, E. J.
    Dolbec, K. S.
    Fawaz, A. S.
    Flood, H. D.
    Giri, S. K.
    [J]. IRISH JOURNAL OF MEDICAL SCIENCE, 2015, 184 : S174 - S174
  • [8] Salvage hypofractionated radiotherapy for prostate cancer: acute toxicity
    Saldi, S.
    Bellavita, R.
    Palumbo, I.
    Mariucci, C.
    Arena, E.
    Lupattelli, M.
    Podlesko, A.
    Russo, S.
    Dottorini, R.
    Bini, V.
    Aristei, C.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2017, 123 : S725 - S725
  • [9] Adjuvant hypofractionated radiotherapy for prostate cancer: acute toxicity
    Saldi, S.
    Bellavita, R.
    Palumbo, I.
    Mariucci, C.
    Arena, E.
    Lupattelli, M.
    Mendichi, M.
    Tenti, M.
    Tamburi, F.
    Bini, V.
    Aristei, C.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2017, 123 : S723 - S723
  • [10] Dosimetric factors predictive of late toxicity in prostate cancer radiotherapy
    de Crevoisier, R.
    Fiorino, C.
    Dubray, B.
    [J]. CANCER RADIOTHERAPIE, 2010, 14 (6-7): : 460 - 468